Letter in Response to "Lomitapide: A Medication Use Evaluation and a Formulary Perspective" by Esba and Alharbi
Glob J Qual Saf Healthc
.
2024 Aug 1;7(3):95.
doi: 10.36401/JQSH-24-17.
eCollection 2024 Aug.
Author
Dirk J Blom
1
Affiliation
1
1Department of Medicine and Cape Heart Institute, University of Cape Town, Cape Town, South Africa.
PMID:
39104801
PMCID:
PMC11298042
DOI:
10.36401/JQSH-24-17
No abstract available